Agilent Reports Strong Q3 FY2025 Results with Double-Digit Revenue Growth
Agilent Technologies announced its financial results for the third quarter of fiscal year 2025, ending July 31, showcasing continued momentum and outperformance against guidance. The company reported total revenue of $1.74 billion, reflecting a 10.1% increase on a reported basis and 6.1% growth in core revenue compared to the same quarter in 2024.
Profitability Continues to Strengthen
Agilent’s profitability also saw strong gains in Q3. The company posted GAAP net income of $336 million, or $1.18 per diluted share, compared to $282 million or $0.97 per share in the third quarter of 2024. On a non-GAAP basis, net income rose to $390 million, or $1.37 per share, up from $385 million or $1.32 per share during the same period last year.
CEO Commentary: Operational Excellence and Strategic Execution
Agilent President and CEO Padraig McDonnell emphasized the importance of the company’s operational model and strategic execution in driving these results.
“Our third-quarter performance, which marks our fifth consecutive quarter of sequential core-revenue acceleration, is a testament to the success of our Ignite Transformation and our laser-like focus on profitable growth and operational excellence,” McDonnell stated.
He added that all three business segments showed growth, alongside expansion across all global regions and in Agilent’s two largest end markets.
“Our Ignite enterprise operating model enables us to quickly adapt in a highly dynamic macro environment while maintaining strong execution, a robust innovation pipeline, and deep customer relationships.”
Segment Performance Highlights
Agilent has made changes to its segment reporting structure starting in fiscal 2025. These adjustments, which have no impact on the company’s consolidated financials, provide improved insight into each business unit’s contributions.
Life Sciences and Diagnostics Group (LDG)
The Life Sciences and Diagnostics Markets Group reported third-quarter revenue of $670 million, representing a 14% year-over-year increase on a reported basis and 7% growth in core terms. LDG’s operating margin was 17.6%, supported by strong demand for diagnostic technologies and continued investment in life sciences.
Agilent CrossLab Group (ACG)
The Agilent CrossLab Group, which provides services, consumables, and laboratory workflow solutions, delivered Q3 revenue of $744 million. This marks an 8% increase reported and 5% in core revenue year-over-year. ACG maintained a strong operating margin of 33.3%, reflecting high efficiency and consistent demand for service and support offerings.
Applied Markets Group (AMG)
The Applied Markets Group posted revenue of $324 million in the third quarter, growing 7% reported and 5% core year-over-year. AMG achieved an operating margin of 21.8%, bolstered by demand in environmental, energy, and food testing markets.
Guidance Raised for Fiscal 2025
Given the strong third-quarter performance, Agilent has raised its full-year financial outlook. The company now expects full-year 2025 revenue to be in the range of $6.91 billion to $6.93 billion, representing reported growth of 6.2% to 6.5%, and core growth of 4.3% to 4.6%.
On a non-GAAP basis, full-year earnings per share (EPS) are projected to be between $5.56 and $5.59.
Q4 2025 Outlook
Looking ahead to the fourth quarter, Agilent projects revenue between $1.822 billion and $1.842 billion, which represents reported growth of 7.1% to 8.3%, and core growth of 4.8% to 6.0%.
Non-GAAP EPS for Q4 is forecasted in the range of $1.57 to $1.60 per share.
Strategic Focus Moving Forward
Agilent’s financial results signal not only resilience but also a strategic pivot toward long-term transformation. The Ignite Transformation initiative, launched to streamline operations, enhance agility, and focus on customer-centric innovation, appears to be driving results across the board.
The company’s consistent core revenue acceleration, robust margin performance, and global expansion reflect a well-balanced growth strategy that leverages both operational efficiency and strategic investments in innovation.
Agilent’s ongoing commitment to strengthening customer relationships and investing in its solutions portfolio positions it well for sustained success in its core scientific and diagnostic markets.
